Early Recurrence After Initial Hepatectomy for Colorectal Liver Metastases
Open Access
- 1 July 2019
- journal article
- research article
- Published by International College of Surgeons in International Surgery
- Vol. 104 (7-8) , 375-382
Abstract
This study investigated the frequency of early recurrence in patients who had undergone hepatectomy for colorectal cancer liver metastasis (CRLM) and assessed the indications for adjuvant chemotherapy in these patients. This retrospective analysis included 133 consecutive patients who underwent initial hepatectomy for CRLM between April 2000 and May 2010 and have been followed more than 5 years. Of the 133 patients, 83 (62%) experienced tumor recurrence, with 14 of the 83 recurrences within 6 months after initial hepatectomy. Overall survival was significantly poorer in patients with recurrences within 6 months than those without any recurrence (P = 0.015). The frequency of adjuvant chemotherapy was significantly lower in patients with recurrences within 6 months than those without recurrences within 6 months. Multivariate analysis showed that H-2 classification was the only independent risk factor for recurrence within 6 months after hepatectomy (P = 0.002). Adjuvant chemotherapy improved prognosis in patients classified as H2. Patients who experienced tumor recurrence within 6 months after initial hepatectomy for CRLM had a poorer prognosis than patients who experienced recurrence after 6 months. Patients with H2-classification of CRLM should receive preoperative adjuvant chemotherapy.Keywords
This publication has 29 references indexed in Scilit:
- Risk factors for early recurrence after curative hepatectomy for colorectal liver metastasesSurgery Today, 2011
- A novel method using the VIO soft-coagulation system for liver resectionSurgery, 2011
- Conditional Survival after Surgical Resection of Colorectal Liver Metastasis: An International Multi-Institutional Analysis of 949 PatientsJournal of the American College of Surgeons, 2010
- Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trialThe Lancet, 2008
- Short Time to Recurrence After Hepatic Resection Correlates with Poor Prognosis in Colorectal Hepatic MetastasisJapanese Journal of Clinical Oncology, 2006
- Prognostic factors and evaluation of surgical management of hepatic metastases from colorectal origin: a 10-year single-institute experienceJournal of Gastrointestinal Surgery, 2005
- Recurrence and Outcomes Following Hepatic Resection, Radiofrequency Ablation, and Combined Resection/Ablation for Colorectal Liver MetastasesAnnals of Surgery, 2004
- FOLFIRI Followed by FOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer: A Randomized GERCOR StudyJournal of Clinical Oncology, 2004
- Liver Resection for Colorectal MetastasesAnnals of Surgery, 2003
- TNM, sixth edition: New developments in general concepts and rulesSeminars in Surgical Oncology, 2003